Article

Evaluation of ROS1 expression and rearrangements in a large cohort of early- stage lung cancer

2022-09-06

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> ROS1 fusion is an infrequent, but attractive target for therapy in patients with metastatic non- small-cell lung cancer. In studies on mainly late-stage disease, the prevalence of ROS1 fusions is about 1-3%. Less is known about the prevalence of ROS1 fusions in early-stage, resectable lung cancer, where it might provide a fruitful target for neoadjuvant or adjuv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c75bd89f-51dc-5d83-bab0-ed20f01d4578
DOI: 10.21203/rs.3.rs-2021302/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of ROS1 expression and rearrangements in a large cohort of early- stage lung cancerDOI 10.21203/rs.3.rs-2021302/v1Read

“Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”Semantic proximity Read

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectivesSemantic proximity Read

Progress of non-small-cell lung cancer with ROS1 rearrangementSemantic proximity Read

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.Semantic proximity Read

High prevalence of ROS1 gene rearrangement detected by FISH in EGFR and ALK negative lung adenocarcinoma.Semantic proximity Read

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to DateSemantic proximity Read

[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].Semantic proximity Read

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING StudySemantic proximity Read

Survival of Patients with Advanced Non-Small Cell Lung Cancer Harboring Different ROS1 Fusion Subtypes: A Real-World StudySemantic proximity Read

Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant AlterationsSemantic proximity Read

High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung Cancer.Semantic proximity Read

Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.Semantic proximity Read